HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBI) announced today the publication of results of its Menaflex™ Collagen Meniscus Implant Clinical Trial in the July 2008 issue of The Journal of Bone and Joint Surgery (“JBJS”) American Volume.
